Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Texas state judge won't block Kenvue from paying dividend, company lawyer says
12:42pm, Friday, 14'th Nov 2025
A Texas state judge won't block Kenvue from paying its scheduled November 26 shareholder dividend, rejecting a request by Texas Attorney General Ken Paxton, a Kenvue lawyer told Reuters on Friday.
Judge to weigh if Texas AG can block Kenvue dividend over Tylenol
06:05am, Friday, 14'th Nov 2025
A Texas judge on Friday will consider state Attorney General Ken Paxton's bid to block Kenvue from paying a $398 million dividend to shareholders and from marketing Tylenol as safe for pregnant women.
Advisors Capital Management LLC Purchases 106,677 Shares of Kenvue Inc. $KVUE
03:12am, Friday, 14'th Nov 2025
Advisors Capital Management LLC lifted its position in shares of Kenvue Inc. (NYSE: KVUE) by 7.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and
Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56
01:53pm, Monday, 10'th Nov 2025
The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - ar
What Moved Markets This Week
07:28am, Saturday, 08'th Nov 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Texas seeks to block Kenvue dividend amid Tylenol lawsuit
08:06am, Thursday, 06'th Nov 2025
Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.
04:44am, Thursday, 06'th Nov 2025
Enbridge has a low-risk business that pays a steady and growing dividend. Kenvue's pending acquisition by Kimberly-Clark creates a great opportunity for income investors.
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction
11:43am, Wednesday, 05'th Nov 2025
On Nov. 3rd, Wall Street rendered a swift and brutal verdict on Kimberly-Clark's NASDAQ: KMB transformative acquisition of Kenvue NYSE: KVUE. While Kenvue's shares climbed over 12%, Kimberly-Clark's s
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kenvue Inc. (NYSE: KVUE)
06:00pm, Tuesday, 04'th Nov 2025
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder
Watch These Stocks Falling 10% Or More
04:58pm, Tuesday, 04'th Nov 2025
Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) su
Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue
02:26pm, Tuesday, 04'th Nov 2025
Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred r
21,714 Shares in Kenvue Inc. $KVUE Acquired by World Investment Advisors
04:31am, Tuesday, 04'th Nov 2025
World Investment Advisors acquired a new stake in Kenvue Inc. (NYSE: KVUE) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acqui
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?
03:23am, Tuesday, 04'th Nov 2025
Kimberly-Clark is merging with Kenvue. The deal brings together two companies with long histories of growing their dividends.
The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker
10:00pm, Monday, 03'rd Nov 2025
Mike Hsu aims to stoke the consumer company's growth by veering into Kenvue's higher-margin but risky health products.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
